Skip to Content

West-ward 3189 (Lithium 300 mg)

Pill with imprint West-ward 3189 is Gray & Yellow, Capsule-shape and has been identified as Lithium carbonate 300 mg. It is supplied by West-Ward Pharmaceutical Corporation.

Lithium is used in the treatment of bipolar disorder; borderline personality disorder; schizoaffective disorder; mania; cyclothymic disorder (and more), and belongs to the drug class miscellaneous antipsychotic agents. There is positive evidence of human fetal risk during pregnancy. Lithium 300 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for West-ward 3189

Lithium carbonate

Imprint:
West-ward 3189
Strength:
300 mg
Color:
Gray & Yellow
Size:
20.00 mm
Shape:
Capsule-shape
Availability:
Prescription only
Drug Class:
Miscellaneous antipsychotic agents
Pregnancy Category:
D - Positive evidence of risk
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
West-Ward Pharmaceutical Corporation
Inactive Ingredients:
magnesium silicate
gelatin
titanium dioxide
butyl alcohol
propylene glycol
ferrosoferric oxide
FD&C Green No. 3
FD&C Yellow No. 6
Note: Inactive ingredients may vary.

Other Labelers / Repackagers:

NDC CodeLabeler / Repackager
63739-0265 McKesson Packaging Services
43063-0196 PDRX Pharmaceuticals Inc. (repackager)

Get help with Imprint Code FAQs.

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2018 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide